Lucid - Providing Better Imaging Tools for Dermatologists

Mounting evidence shows that physicians need better tools to assist in the identification of skin disease. For example, until recently dermatologists had to rely on limited information such as patient history and their senses of sight and touch to assess skin conditions. Whereas specialties such as radiology have used advanced noninvasive imaging medical technologies such as CT scanners and MRI imagers for many years, dermatologists often had at most an illuminated magnifying glass to assist them with diagnosis. Simply put, dermatologists need 21st century tools.

Lucid is changing the game by providing dermatologists its VivaScope® confocal imagers - the highest resolution commercially available medical skin imaging device - to assist them in quickly forming a clinical judgment regarding difficult skin conditions. This patented technology - routinely in use at leading medical centers around the World - provides extremely high, cellular resolution images of a patient's skin. Due to the completion of significant clinical studies in Europe and Australia, deployment of our technology in dermatology clinics is already underway in these regions. Large clinical trials now underway in the United States should allow widespread deployment to begin in the U.S. in 2009.

Roll-out of new medical technology is often limited by the time needed to train physicians in its use. VivaNet®, Lucid's networked telemedicine medical image server should shorten this obstacle to adoption. VivaNet® quickly and securely transfers VivaScope images and other critical patient information between medical professionals to enable near real-time collaboration and consultations. Thus, dermatologists can transfer images and receive opinions from other medical professionals to assist them in forming clinical judgments faster than ever before possible.

Lucid designs, produces and distributes its innovative technologies worldwide. Learn more about our capabilities at this web site and contact us if you need further information.